SensoDetect Investor Relations Material
Latest events
Q2 2025
29 Aug, 2025
Q1 2025
30 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SensoDetect
Access all reports
SensoDetect AB is a Sweden-based medical technology company specializing in objective diagnostic tools for mental health. The company develops and markets the SensoDetect BERA system, which uses auditory brainstem response analysis to support the diagnosis of neuropsychiatric disorders such as ADHD, autism, and schizophrenia. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
SDET
Country
🇸🇪 Sweden